fortum for injection 2 gvial
glaxosmithkline pte ltd - ceftazidime pentahydrate eqv ceftazidime - injection, powder, for solution - 2 g/vial - ceftazidime pentahydrate eqv ceftazidime 2 g/vial
padcev powder for solution
seagen inc. - enfortumab vedotin - powder for solution - 20mg - enfortumab vedotin 20mg - antineoplastic agents
padcev powder for solution
seagen inc. - enfortumab vedotin - powder for solution - 30mg - enfortumab vedotin 30mg - antineoplastic agents
fortum
aspen pharmacare australia pty ltd - ceftazidime -
fortum
glaxosmithkline manufacturing s.p.a. - ceftazidime (ceftazidime pentahydrate) - powder for solution for injection/infusion - 500mg
fortum
glaxosmithkline manufacturing s.p.a. - ceftazidime (ceftazidime pentahydrate) - powder for solution for injection/infusion - 1000mg
fortum 1g powder for injection vial
aspen pharmacare australia pty ltd - ceftazidime pentahydrate, quantity: 1.164 g (equivalent: ceftazidime, qty 1 g) - injection, powder for - excipient ingredients: sodium carbonate - fortum is indicated for the treatment of single and mixed infections caused by susceptible aerobic organisms with suspected or documented resistance to other antimicrobials , but not to ceftazidime, and as an alternative to aminoglycosides in pseudomonal infection in patients in whom aminoglycoside toxicity is a cause for concern and other pseudomonal antibiotics cannot be used. indications include: severe infections in general: for example septicaemia, including neonatal sepsis, bacteraemia, and in patients in intensive care units with specific problems, e.g., infected burns. respiratory tract infections: for example, pneumonia, bronchopneumonia, infected pleurisy, infected bronchiectasis and bronchitis. severe ear, nose and throat infections: for example, otitis media, mastoiditis. urinary tract infections: for example, acute and chronic pyelonephritis, pyelitis, cystitis, urethritis (bacterial only), and infections associated with bladder and renal stones. skin and soft tissue infections: for example, erys
fortum powder for solution for injection/infusion
glaxosmithkline manufacturing spa - ceftazidime (ceftazidime pentahydrate) - powder for solution for injection/infusion - 500mg
fortum powder for solution for injection/infusion
glaxosmithkline manufacturing s.p.a. - ceftazidime (ceftazidime pentahydrate) - powder for solution for injection/infusion - 1000mg
padcev® powder for concentrate for solution for infusion 20mgvial
astellas pharma singapore pte. ltd. - enfortumab vedotin - injection, powder, lyophilized, for solution - enfortumab vedotin 20.0 mg/vial